Another Off-Label Claim Dispute between Industry and FDA: Amarin’s Vascepa (Omega 3 Fatty Acid)
FDA strictly enforces prevention of off-label promotion of products. In the recent past, there have been numerous cases of FDA’s punitive actions against companies and individuals accused of off-label promotion. US courts have repeated sided with FDA in agreeing that off-label promotion is not protected by free speech rights. Now Amarin Corporation, the manufacturer of … Read more